ATS Life Sciences
ATS Life Sciences, headquartered in California, is a prominent player in the life sciences industry, specialising in advanced automation solutions and integrated systems for pharmaceutical and biotechnology sectors. Founded in 2001, the company has achieved significant milestones, including the development of innovative technologies that enhance laboratory efficiency and accuracy. With a focus on core services such as laboratory automation, data management, and custom software solutions, ATS Life Sciences stands out for its commitment to quality and precision. The company has established a strong market position, recognised for its expertise in streamlining complex workflows and improving operational outcomes. Through its dedication to innovation and customer satisfaction, ATS Life Sciences continues to lead the way in transforming the landscape of life sciences automation.
DitchCarbon Score
How does ATS Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ATS Life Sciences's score of 25 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ATS Life Sciences's reported carbon emissions
In 2023, ATS Life Sciences reported total carbon emissions of approximately 27,074,570 kg CO2e across all scopes. This includes Scope 1 emissions of about 27,074,570 kg CO2e, Scope 2 emissions also at approximately 27,074,570 kg CO2e, and Scope 3 emissions, which are primarily from purchased goods and services, amounting to the same figure of about 27,074,570 kg CO2e. Comparatively, in 2022, the company recorded total emissions of around 24,570,490 kg CO2e, indicating a rise in emissions from the previous year. In 2021, emissions were approximately 32,165,170 kg CO2e, and in 2020, they peaked at about 36,202,590 kg CO2e. This data suggests a fluctuating trend in emissions over the past few years. Despite the lack of specific reduction targets or initiatives disclosed, ATS Life Sciences is actively monitoring its carbon footprint across all scopes. The company has not set formal science-based targets or climate pledges, which may indicate an area for future commitment and improvement in their sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 36,202,590 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 36,202,590 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 36,202,590 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ATS Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
